Seeking Alpha

Nahodny Okoloiduci

Nahodny Okoloiduci
Send Message
View as an RSS Feed
View Nahodny Okoloiduci's Comments BY TICKER:
Latest  |  Highest rated
  • Apple Breaks Below Its 200-Day [View article]
    now that's some expertise!
    Nov 5 05:36 PM | 5 Likes Like |Link to Comment
  • Market recap: Stocks failed to hold early gains after the nonfarm payrolls report exceeded expectations, as investors adjusted positions ahead of next week's presidential election. The dollar rallied and commodities plunged (I, II), which weighed energy and materials shares, as the jobs data sparked QE doubts. NYSE decliners topped advancers nearly three to one. [View news story]
    market deals with uncertainties and hard to quantify risks every single day
    Nov 3 01:15 PM | 1 Like Like |Link to Comment
  • Shareholders Could Benefit From Seadrill's Potential Purchase Of Songa Eclipse [View article]
    Songa need the cash badly.
    Oct 30 01:19 PM | Likes Like |Link to Comment
  • This $1 Biotech Stock Offers Limited Downside With Huge Reward Potential [View article]
    what stock are you refering to?
    Oct 26 12:44 PM | 1 Like Like |Link to Comment
  • This $1 Biotech Stock Offers Limited Downside With Huge Reward Potential [View article]
    of course it had not, it's baby biotech..
    Oct 26 03:29 AM | 1 Like Like |Link to Comment
  • More on Amazon (AMZN): Q3 loss includes a $0.37 per share hit from LivingSocial related to impairment. Product revenue +23.1% Y/Y to $11.55B. Service revenue +51% Y/Y to $2.26B Company expects Q4 net sales of $20.25B-$22.75B. Shares -6.5% AH. Conference call at 5:00 ET. (PR[View news story]
    everything above $30 - 40 is good enough
    Oct 25 04:30 PM | Likes Like |Link to Comment
  • This $1 Biotech Stock Offers Limited Downside With Huge Reward Potential [View article]
    ..and you must be shortie.

    Seriously, people, stop this BS, this is not some yahoo board. Bring your (valid) arguments or stay quiet.
    Oct 25 03:28 PM | 16 Likes Like |Link to Comment
  • This $1 Biotech Stock Offers Limited Downside With Huge Reward Potential [View article]
    I think FDA behavior @Northera approval process was kinda scandalous (although not as scandalous as in MNKD case), but I'm pretty confident that Northera will be approved.
    Oct 25 02:27 PM | 3 Likes Like |Link to Comment
  • Questcor (QCOR): Q3 EPS of $0.91 beats by $0.14. Revenue of $140.3M beats by $11M. (PR[View news story]
    oh sorry wrong ticker... thought im in TPX thread
    Oct 23 05:10 PM | 1 Like Like |Link to Comment
  • Questcor (QCOR): Q3 EPS of $0.91 beats by $0.14. Revenue of $140.3M beats by $11M. (PR[View news story]
    they cut the outlook
    Oct 23 04:46 PM | Likes Like |Link to Comment
  • Insiders Bought These Shares On October 16 [View article]
    @TROX
    "The stock has fallen 84.43% year to date."

    No, it has not. How about some 1:5 split in July?
    Oct 23 12:32 PM | Likes Like |Link to Comment
  • OM Group (OMG +6%) gets a boost after KeyBanc says if OMG sells its 55% stake in a Congo joint venture and its Finland cobalt refinery, "this would be a catalyst for shares to move well above the current share price... in a relatively short period of time." If the deal goes through. the firm sees strong upside potential in OMG shares while the downside risk is "relatively minimal." [View news story]
    what a clever ticker
    Oct 22 04:07 PM | Likes Like |Link to Comment
  • Price Pressure And Competition Produce A Negative Inflection Point For Skullcandy [View article]
    "38% of the total outstanding share count is held short"

    You would rather consider % of the shorts out of the float, which is pretty around 65%. That is very risky.
    Oct 21 06:40 AM | 1 Like Like |Link to Comment
  • Trading Spectrum Pharmaceuticals - A Closer Look [View article]
    Let's see it from co's point of view. It's half developmental/half market bio company. The are making cash, but they need the cash in spite to grow their business (SPPI have pretty wide dev pipeline). For me, it makes no sense to carve the money out of the business (means not growing or need of fin.leverage) and giving them to investors at this stage of SPPI life. Remember they just authorized share buyback to USD 100mil. (was 10mil?).
    SPPI don't primarily care of shorts as well as I don't care about em. They care about making money.
    Why don't you just take advantage of the price as well as SPPI is taking (buyback)?
    Value is obvious and for bargain.
    Oct 17 10:18 AM | 1 Like Like |Link to Comment
  • Trading Spectrum Pharmaceuticals - A Closer Look [View article]
    dividend makes no sense right now
    still i think SPPI will be trading at more than $30 soon, based on conservative valuation
    Oct 17 03:05 AM | 1 Like Like |Link to Comment
COMMENTS STATS
141 Comments
116 Likes